Uranium Stocks: Extreme Breadth Weakness and Deepening Drawdowns

1. A week that confirms deterioration

The uranium market is undergoing a correction that cannot be explained solely by weakness in a few volatile securities. The week ended October 16, 2026, brought broad price declines, exceptionally weak breadth and selling pressure across the 75-instrument research universe.

56 instruments declined, 17 advanced and two were unchanged. The median weekly return was −7.05%, versus −2.33% in the preceding week; the mean fell to −6.36%. Yet the real extent of the damage emerges beneath headline prices: only eight securities remain above MA200, the median 52-week drawdown approaches 50%, and signed volume remains negative.

This is not a shallow correction. A substantial part of the universe has been weak for some time, and the latest week has intensified that process.

2. Breadth: just eight securities retain their long-term trend

Only 11.11% of securities with valid data trade above their 200-session moving average, down from 16.67% one week earlier. Both dates have 72 valid observations. On the common 72-security four-week sample, the share above MA200 fell from 26.39% to 11.11%.

Nearly nine out of ten instruments with sufficient history are below their long-term trend reference. Median distance from MA200 deteriorated from −20.67% to −26.65%. The weakness is therefore not confined to a few days of losses: much of the universe remains far below its long-term trend.

Such depressed breadth can occur late in a correction, but extreme weakness alone is not a buy signal. A structural recovery would require a sustained rebuilding of participation, with more securities reclaiming their long-term averages.

3. Drawdown breadth: destruction of value spreads

Drawdowns from 52-week closing highs reinforce the same conclusion. 84.72% of instruments with valid observations stand more than 30% below their highs, while 48.61% are more than 50% below. Median 52-week drawdown has reached −49.83%, versus −45.37% one week earlier.

Measured from each instrument's highest closing price across its available history, median drawdown is even deeper: −84.39%. This longer-history measure requires caution because histories differ in length and securities did not necessarily peak during the same cycle.

Even so, the overall picture is clear: much of the universe has suffered substantial accumulated losses. A recovery in a few large ETFs or companies would not alone establish that this damage has ended.

4. Volume: selling pressure gains prominence

Median relative volume over five sessions is approximately 1.01× the prior 60-session reference. There is no extraordinary, universe-wide volume surge. However, the distribution of volume between rising and falling securities remains unfavorable.

Median 20-session signed volume balance worsened to −20.11%, from −18.90% previously. The original Weekly Analysis summary records 12 declining instruments and four advancing instruments combining five-session direction with relative volume of at least 1.5×. These are the verified counts, correcting the provisional Spanish draft.

Activity is not increasing uniformly, but where unusually high relative volume appears, declines predominate. This is not proof of institutional selling or a definitive capitulation. The current volume profile does not yet show convincing broad accumulation.

5. Major sector benchmarks are also under pressure

The correction reaches beyond small exploration companies. The sector's major ETFs all declined sharply:

Established uranium names also show substantial weakness:

Several nuclear technology companies were hit particularly hard: Oklo fell 19.39%, NuScale Power 19.03% and Centrus Energy 19.31%. The correction extends beyond traditional producers. Because this universe includes utilities, industrial businesses, technology companies and ETFs, not all instruments have the same economic exposure to uranium prices.

6. Relative strength survives, but is highly concentrated

Some instruments managed to finish the week higher, despite the market-wide weakness:

Haranga's 35.71% weekly rebound must be considered alongside its −62.93% year-to-date performance. Berkeley Energia shows a different profile: +9.44% for the week, +65.29% over four weeks, and first place in the supplied global ranking.

These exceptions do not offset widespread weakness. 47 of 75 securities lost at least 5% during the week; 22 declined 10% or more. This is a market of isolated positive exceptions, not a broadly participatory recovery.

7. Comparison with the broader equity market

The S&P 500 benchmark series included in Weekly Analysis declined 1.95% during the week, versus the uranium universe's −7.05% median. Only 23 of 75 instruments outperformed the index. Importantly, outperforming a falling benchmark does not necessarily mean posting a positive return.

Rather than displaying relative leadership, uranium and nuclear securities amplified the broader market's weekly weakness.

8. Opportunity or an unfinished correction?

The depth of the losses raises an unavoidable question: is uranium approaching seller exhaustion? Breadth at 11.11%, median 52-week drawdown near 50%, and a high share of deeply depressed securities describe an exceptionally battered market.

But being severely beaten down is not the same as forming a bottom. Signed volume remains unfavorable, breadth is deteriorating and major ETFs have yet to establish a sustained recovery.

Stabilization

Losses moderate, fewer securities make new lows, and volume balance improves. This would be an early constructive sign, but not yet a confirmed trend reversal.

Recovery

MA200 breadth rises sustainably, uranium equities regain relative strength against broader benchmarks, and major ETFs begin forming higher highs and higher lows.

Continued decline

Selling persists, rebounds remain concentrated in a few names, and participation continues to deteriorate across the universe.

Current data do not establish that the correction has ended. These are conditional scenarios, not predictions of the next market move.

9. Conclusion: market participation is the decisive question

Uranium and nuclear securities exhibit an exceptionally weak internal structure. The correction extends from speculative explorers to established producers, ETFs and nuclear technology companies. Only 11.11% of securities with valid MA200 data remain above that average; nearly 85% are more than 30% below their 52-week highs. Directional volume remains dominated by selling pressure.

Deep corrections can create important future opportunities, but these data do not yet identify a structural recovery. The decisive question is not how much further the sector can fall, but when participation across its components begins to recover. Until then, isolated rebounds warrant caution.

10. Complete ranking and methodology

The interactive ranking below includes all 75 instruments and nine original fields: weekly rank, global rank, ticker, company, last close, 1W, 4W, 3M and YTD. Original positions and missing values are preserved. Desktop and mobile searching, sorting and full ranking copy are provided.

The working Excel and historical data files remain private. See our public methodology and limitations. Indicator denominators vary with available observations, the universe includes heterogeneous nuclear-related businesses, and drawdowns over unequal available histories are not directly comparable.

Complete uranium ranking — 75 securities

Weekly rank, global rank, last close and returns over one week, four weeks, three months and year to date. Search by ticker or company and sort on either device.

Data through October 16, 2026. Independent research for information only. Methodology.